Therapeutic indications and metabolic effects of metreleptin in patients with lipodystrophy syndromes: Real-life experience from a national reference network.

Diabetes Obes Metab · 2022 · PMC9541305 · PMID 35445532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Conversely, the metabolic efficacy of metreleptin in patients with PLD was highly variable, and did not reach statistical significance when considering the whole PLD group.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.